Oncode Institute combines scientific excellence with an integrated, systemic approach - bridging fundamental research, clinical needs and the market. With 1 in 2 people facing cancer in their lifetime and 5 people dying of cancer every hour, the urgency of our mission to outsmart cancer and impact lives has never been greater.
Uniquely positioned in the Netherlands - a global top-5 country in cancer research - we accelerate the translation of innovations into cancer solutions. We believe succeeding in this is a joint effort: we build a strong community among our researchers and foster collaboration across sectors and disciplines. This way, we create tangible impact on health, knowledge and the economy.

Oncode Investigators are chosen through a highly competitive process emphasizing scientific excellence, originality, and translational potential. We select bold, visionary researchers across the Netherlands who push boundaries and embody collaboration and impact-driven science.

Our Major Donor Program invites visionary partners to join us in supporting transformative cancer research and valorisation efforts that make a tangible impact on health and society. See Major Donor

Oncode Institute, in strategic alliance with Oncode Accelerator, unites academic researchers, clinicians, entrepreneurs and investors around one shared goal: bringing innovative cancer therapies to patients faster and more efficiently. Oncode Accelerator is a large-scale, multi-stakeholder programme that accelerates the development of safe, personalized and effective therapies while strengthening the Dutch oncology innovation ecosystem. By integrating, scaling and innovating the Netherlands’ preclinical development infrastructure, it aims to revolutionize how new cancer therapies move from discovery to patient care. More about Oncode Accelerator. 

Valorization is the process of turning breakthrough science into real-world impact. At Oncode Institute, this is driven by a dedicated team of business development and intellectual property experts. Working closely with researchers, they identify promising ideas early, shape them, and guide them toward clinical relevance. This hands-on approach ensures that scientific discoveries don’t just advance knowledge - they steadily move toward tangible benefits for patients. 

Despite the Netherlands’ strength in cancer research, systemic gaps between fundamental science, clinical needs, industry, and market factors can slow the translation of discoveries into benefits for patients. Oncode Institute bridges these divides by connecting researchers, clinicians, industry partners, and patients across the cancer innovation ecosystem, accelerating solutions - because every hour counts when five people in the Netherlands die of cancer.

We know that transformative progress often comes from bold ideas with uncertain outcomes. Oncode actively invests in high-risk, high-reward projects, empowering researchers to explore unconventional paths without fear of failure. This appetite for innovation fuels breakthroughs that traditional funding might overlook.